CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer.

Sci Rep · 2024 · PMC11014850 · PMID 38609450

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an overall trendno p-value reported

Subgroup K-M survival curves of different clinical variables in GBM/LGG, SARC and UCEC also showed an overall trend of poor prognosis with higher CCDC58 expression.

also in 3,008 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.